nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCB1—peripheral nervous system neoplasm	0.164	1	CbGaD
Progesterone—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.0996	0.164	CbGbCtD
Progesterone—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0312	0.0514	CbGbCtD
Progesterone—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0303	0.0498	CbGbCtD
Progesterone—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0295	0.0484	CbGbCtD
Progesterone—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0271	0.0445	CbGbCtD
Progesterone—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0259	0.0426	CbGbCtD
Progesterone—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0226	0.0372	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0223	0.0366	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0207	0.034	CbGbCtD
Progesterone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0207	0.034	CbGbCtD
Progesterone—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0192	0.0316	CbGbCtD
Progesterone—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0176	0.029	CbGbCtD
Progesterone—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0169	0.0278	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0169	0.0278	CbGbCtD
Progesterone—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0163	0.0267	CbGbCtD
Progesterone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0255	CbGbCtD
Progesterone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0149	0.0246	CbGbCtD
Progesterone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0124	0.0204	CbGbCtD
Progesterone—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.012	0.0198	CbGbCtD
Progesterone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0109	0.0179	CbGbCtD
Progesterone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0109	0.0179	CbGbCtD
Progesterone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0104	0.0171	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00994	0.0163	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00951	0.0156	CbGbCtD
Progesterone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00951	0.0156	CbGbCtD
Progesterone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00754	0.0124	CbGbCtD
Progesterone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00713	0.0117	CbGbCtD
Progesterone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00654	0.0107	CbGbCtD
Progesterone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00652	0.0107	CbGbCtD
Progesterone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00628	0.0103	CbGbCtD
Progesterone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00606	0.00996	CbGbCtD
Progesterone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00486	0.008	CbGbCtD
Progesterone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00464	0.00763	CbGbCtD
Progesterone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00446	0.00733	CbGbCtD
Progesterone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00433	0.00712	CbGbCtD
Progesterone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00425	0.00699	CbGbCtD
Progesterone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0029	0.00477	CbGbCtD
Progesterone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00278	0.00457	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.00449	CbGbCtD
Progesterone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00255	0.00419	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00286	CbGbCtD
Progesterone—Drospirenone—BCHE—peripheral nervous system neoplasm	0.000475	0.391	CrCbGaD
Progesterone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.000213	0.175	CrCbGaD
Progesterone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.000132	0.109	CrCbGaD
Progesterone—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000123	0.101	CrCbGaD
Progesterone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000115	0.0948	CrCbGaD
Progesterone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	8.8e-05	0.0725	CrCbGaD
Progesterone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000366	CcSEcCtD
Progesterone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000365	CcSEcCtD
Progesterone—Testosterone—ABCB1—peripheral nervous system neoplasm	6.78e-05	0.0558	CrCbGaD
Progesterone—Asthma—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000363	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000363	CcSEcCtD
Progesterone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000363	CcSEcCtD
Progesterone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	6.75e-05	0.000362	CcSEcCtD
Progesterone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	6.72e-05	0.000361	CcSEcCtD
Progesterone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	6.67e-05	0.000358	CcSEcCtD
Progesterone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	6.66e-05	0.000358	CcSEcCtD
Progesterone—Weight increased—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000357	CcSEcCtD
Progesterone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000355	CcSEcCtD
Progesterone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.61e-05	0.000355	CcSEcCtD
Progesterone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000354	CcSEcCtD
Progesterone—Somnolence—Etoposide—peripheral nervous system neoplasm	6.59e-05	0.000354	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000354	CcSEcCtD
Progesterone—Asthenia—Vincristine—peripheral nervous system neoplasm	6.57e-05	0.000353	CcSEcCtD
Progesterone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000352	CcSEcCtD
Progesterone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.00035	CcSEcCtD
Progesterone—Infestation—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.00035	CcSEcCtD
Progesterone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.00035	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.52e-05	0.00035	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000349	CcSEcCtD
Progesterone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.5e-05	0.000349	CcSEcCtD
Progesterone—Rash—Dactinomycin—peripheral nervous system neoplasm	6.46e-05	0.000347	CcSEcCtD
Progesterone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.45e-05	0.000346	CcSEcCtD
Progesterone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.4e-05	0.000344	CcSEcCtD
Progesterone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.4e-05	0.000344	CcSEcCtD
Progesterone—Fatigue—Etoposide—peripheral nervous system neoplasm	6.39e-05	0.000343	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000343	CcSEcCtD
Progesterone—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000341	CcSEcCtD
Progesterone—Pain—Etoposide—peripheral nervous system neoplasm	6.34e-05	0.000341	CcSEcCtD
Progesterone—Constipation—Etoposide—peripheral nervous system neoplasm	6.34e-05	0.000341	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.00034	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.00034	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.00034	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000338	CcSEcCtD
Progesterone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.28e-05	0.000337	CcSEcCtD
Progesterone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.26e-05	0.000336	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000336	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000331	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000331	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000329	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000328	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.11e-05	0.000328	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000328	CcSEcCtD
Progesterone—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.09e-05	0.000327	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000326	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.06e-05	0.000326	CcSEcCtD
Progesterone—Dizziness—Vincristine—peripheral nervous system neoplasm	6.05e-05	0.000325	CcSEcCtD
Progesterone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.04e-05	0.000324	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000324	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000324	CcSEcCtD
Progesterone—Infestation—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000324	CcSEcCtD
Progesterone—Rash—Alitretinoin—peripheral nervous system neoplasm	5.99e-05	0.000322	CcSEcCtD
Progesterone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.99e-05	0.000321	CcSEcCtD
Progesterone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.96e-05	0.00032	CcSEcCtD
Progesterone—Headache—Alitretinoin—peripheral nervous system neoplasm	5.95e-05	0.00032	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000318	CcSEcCtD
Progesterone—Urticaria—Etoposide—peripheral nervous system neoplasm	5.89e-05	0.000316	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000316	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000316	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000315	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.86e-05	0.000315	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.86e-05	0.000315	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000315	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000315	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000314	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000314	CcSEcCtD
Progesterone—Vomiting—Vincristine—peripheral nervous system neoplasm	5.82e-05	0.000313	CcSEcCtD
Progesterone—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.81e-05	0.000312	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000312	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.00031	CcSEcCtD
Progesterone—Rash—Vincristine—peripheral nervous system neoplasm	5.77e-05	0.00031	CcSEcCtD
Progesterone—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.77e-05	0.00031	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.00031	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000309	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000308	CcSEcCtD
Progesterone—Headache—Vincristine—peripheral nervous system neoplasm	5.74e-05	0.000308	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000306	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000304	CcSEcCtD
Progesterone—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.64e-05	0.000303	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000303	CcSEcCtD
Progesterone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.54e-05	0.000297	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000297	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000294	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.46e-05	0.000293	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000293	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000292	CcSEcCtD
Progesterone—Nausea—Vincristine—peripheral nervous system neoplasm	5.44e-05	0.000292	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000292	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000292	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000291	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000291	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000289	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000287	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000286	CcSEcCtD
Progesterone—Asthenia—Etoposide—peripheral nervous system neoplasm	5.32e-05	0.000286	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000286	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000285	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000285	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000284	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000283	CcSEcCtD
Progesterone—Pruritus—Etoposide—peripheral nervous system neoplasm	5.25e-05	0.000282	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.00028	CcSEcCtD
Progesterone—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000278	CcSEcCtD
Progesterone—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.15e-05	0.000276	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000275	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000275	CcSEcCtD
Progesterone—Rash—Cisplatin—peripheral nervous system neoplasm	5.1e-05	0.000274	CcSEcCtD
Progesterone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.1e-05	0.000274	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000274	CcSEcCtD
Progesterone—Erythema—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000274	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.07e-05	0.000273	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000272	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000271	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.00027	CcSEcCtD
Progesterone—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.00027	CcSEcCtD
Progesterone—Tension—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000268	CcSEcCtD
Progesterone—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000266	CcSEcCtD
Progesterone—Back pain—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000265	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000264	CcSEcCtD
Progesterone—Dizziness—Etoposide—peripheral nervous system neoplasm	4.9e-05	0.000263	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000263	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000263	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000262	CcSEcCtD
Progesterone—Nausea—Cisplatin—peripheral nervous system neoplasm	4.81e-05	0.000258	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000258	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000257	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000255	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000254	CcSEcCtD
Progesterone—Vomiting—Etoposide—peripheral nervous system neoplasm	4.72e-05	0.000253	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000253	CcSEcCtD
Progesterone—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000253	CcSEcCtD
Progesterone—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000253	CcSEcCtD
Progesterone—Rash—Etoposide—peripheral nervous system neoplasm	4.68e-05	0.000251	CcSEcCtD
Progesterone—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000251	CcSEcCtD
Progesterone—Headache—Etoposide—peripheral nervous system neoplasm	4.65e-05	0.00025	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000249	CcSEcCtD
Progesterone—Tension—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000248	CcSEcCtD
Progesterone—Malaise—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000247	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000246	CcSEcCtD
Progesterone—Vertigo—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000246	CcSEcCtD
Progesterone—Syncope—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000245	CcSEcCtD
Progesterone—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000245	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000243	CcSEcCtD
Progesterone—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000242	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.00024	CcSEcCtD
Progesterone—Cough—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000239	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000239	CcSEcCtD
Progesterone—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000237	CcSEcCtD
Progesterone—Nausea—Etoposide—peripheral nervous system neoplasm	4.41e-05	0.000237	CcSEcCtD
Progesterone—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000236	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000235	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000234	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000233	CcSEcCtD
Progesterone—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000233	CcSEcCtD
Progesterone—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000233	CcSEcCtD
Progesterone—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000232	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000231	CcSEcCtD
Progesterone—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.00023	CcSEcCtD
Progesterone—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000228	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000228	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000227	CcSEcCtD
Progesterone—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000227	CcSEcCtD
Progesterone—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000225	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000224	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000223	CcSEcCtD
Progesterone—Oedema—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000223	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000222	CcSEcCtD
Progesterone—Infection—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000222	CcSEcCtD
Progesterone—Cough—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000221	CcSEcCtD
Progesterone—Shock—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.00022	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000219	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000219	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000219	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000218	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000217	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000216	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000216	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000216	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000216	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000215	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000214	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000213	CcSEcCtD
Progesterone—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000213	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000211	CcSEcCtD
Progesterone—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000209	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000208	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000207	CcSEcCtD
Progesterone—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000207	CcSEcCtD
Progesterone—Infection—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000205	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000203	CcSEcCtD
Progesterone—Shock—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000203	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000203	CcSEcCtD
Progesterone—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000202	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000202	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000201	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.0002	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.0002	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000199	CcSEcCtD
Progesterone—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000198	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000197	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000197	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000194	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000193	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000193	CcSEcCtD
Progesterone—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000192	CcSEcCtD
Progesterone—Constipation—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000191	CcSEcCtD
Progesterone—Pain—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000191	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000188	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000187	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000186	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000184	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000184	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000184	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000183	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000182	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.00018	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000178	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000178	CcSEcCtD
Progesterone—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.000177	CcSEcCtD
Progesterone—Pain—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000177	CcSEcCtD
Progesterone—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000177	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000176	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000176	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.00017	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000169	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000164	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000164	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000163	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000163	CcSEcCtD
Progesterone—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.00016	CcSEcCtD
Progesterone—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000158	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000153	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000152	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000148	CcSEcCtD
Progesterone—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000148	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000146	CcSEcCtD
Progesterone—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000142	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000141	CcSEcCtD
Progesterone—Rash—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000141	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000141	CcSEcCtD
Progesterone—Headache—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.00014	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000137	CcSEcCtD
Progesterone—Nausea—Epirubicin—peripheral nervous system neoplasm	2.47e-05	0.000133	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000131	CcSEcCtD
Progesterone—Rash—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.00013	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.00013	CcSEcCtD
Progesterone—Headache—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000129	CcSEcCtD
Progesterone—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	0.000123	CcSEcCtD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.03e-05	0.000501	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.02e-05	0.000499	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2e-05	0.000495	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2e-05	0.000493	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.99e-05	0.00049	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	1.97e-05	0.000486	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.94e-05	0.00048	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	1.93e-05	0.000477	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.9e-05	0.000468	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.89e-05	0.000466	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.89e-05	0.000466	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.88e-05	0.000464	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.000461	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.86e-05	0.00046	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	1.85e-05	0.000457	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.85e-05	0.000457	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.85e-05	0.000456	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000455	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.00045	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.8e-05	0.000445	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.8e-05	0.000444	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.77e-05	0.000438	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.77e-05	0.000437	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000434	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.75e-05	0.000431	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.74e-05	0.000429	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.73e-05	0.000428	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.72e-05	0.000424	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000423	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000421	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.7e-05	0.00042	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.68e-05	0.000415	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.68e-05	0.000414	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.67e-05	0.000413	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.66e-05	0.00041	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.65e-05	0.000407	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.62e-05	0.000401	CbGpPWpGaD
Progesterone—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.000399	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.61e-05	0.000398	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.59e-05	0.000394	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.58e-05	0.00039	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.58e-05	0.00039	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.55e-05	0.000383	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.53e-05	0.000377	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	0.000376	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.52e-05	0.000375	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.51e-05	0.000373	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-05	0.000373	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.5e-05	0.000371	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.000366	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.46e-05	0.000361	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.46e-05	0.000361	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.46e-05	0.00036	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.46e-05	0.000359	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.45e-05	0.000359	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.45e-05	0.000358	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000358	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.42e-05	0.000351	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000351	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.42e-05	0.00035	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.41e-05	0.000349	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000345	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.4e-05	0.000345	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.39e-05	0.000344	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.39e-05	0.000343	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000339	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.37e-05	0.000338	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—MYC—peripheral nervous system neoplasm	1.37e-05	0.000338	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000336	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.000334	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000333	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000331	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.33e-05	0.000329	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.32e-05	0.000326	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.32e-05	0.000325	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.31e-05	0.000323	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000319	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.29e-05	0.000318	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.28e-05	0.000317	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000312	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.25e-05	0.000308	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000308	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.24e-05	0.000306	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.24e-05	0.000305	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.23e-05	0.000305	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.000304	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.22e-05	0.0003	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.21e-05	0.000298	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.19e-05	0.000294	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.19e-05	0.000294	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.000291	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000291	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000291	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.16e-05	0.000287	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.16e-05	0.000287	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.15e-05	0.000284	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000284	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.15e-05	0.000283	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.14e-05	0.00028	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-05	0.00028	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.12e-05	0.000277	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000273	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.1e-05	0.000271	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.09e-05	0.00027	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.09e-05	0.00027	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000269	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.08e-05	0.000267	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.000267	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000267	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000265	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.000264	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.07e-05	0.000263	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.06e-05	0.000261	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.00026	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.05e-05	0.00026	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.000255	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.02e-05	0.000251	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.01e-05	0.000249	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1e-05	0.000247	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1e-05	0.000247	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	9.71e-06	0.00024	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.69e-06	0.000239	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—AKT1—peripheral nervous system neoplasm	9.5e-06	0.000235	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	9.49e-06	0.000234	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.48e-06	0.000234	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.36e-06	0.000231	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	9.31e-06	0.00023	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.3e-06	0.00023	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	9.16e-06	0.000226	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	9.03e-06	0.000223	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	8.94e-06	0.000221	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.92e-06	0.00022	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.9e-06	0.00022	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	8.83e-06	0.000218	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	8.7e-06	0.000215	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.67e-06	0.000214	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.54e-06	0.000211	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.53e-06	0.00021	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	8.45e-06	0.000208	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	8.4e-06	0.000207	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MYC—peripheral nervous system neoplasm	8.35e-06	0.000206	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.18e-06	0.000202	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.18e-06	0.000202	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.12e-06	0.0002	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.06e-06	0.000199	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.98e-06	0.000197	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	7.94e-06	0.000196	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.78e-06	0.000192	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.74e-06	0.000191	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.72e-06	0.000191	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.66e-06	0.000189	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.59e-06	0.000187	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	7.52e-06	0.000186	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.51e-06	0.000185	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.49e-06	0.000185	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.46e-06	0.000184	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.39e-06	0.000182	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.28e-06	0.00018	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	7.14e-06	0.000176	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.95e-06	0.000172	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.91e-06	0.000171	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	6.86e-06	0.000169	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.75e-06	0.000166	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.73e-06	0.000166	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.63e-06	0.000164	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.59e-06	0.000163	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.5e-06	0.00016	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.48e-06	0.00016	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.43e-06	0.000159	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.37e-06	0.000157	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.36e-06	0.000157	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—peripheral nervous system neoplasm	6.36e-06	0.000157	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6.36e-06	0.000157	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.34e-06	0.000157	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.3e-06	0.000156	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.06e-06	0.00015	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.01e-06	0.000148	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6e-06	0.000148	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.98e-06	0.000148	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.94e-06	0.000147	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.92e-06	0.000146	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.83e-06	0.000144	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.83e-06	0.000144	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—peripheral nervous system neoplasm	5.79e-06	0.000143	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.69e-06	0.00014	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.65e-06	0.000139	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.49e-06	0.000136	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.44e-06	0.000134	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	5.43e-06	0.000134	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.43e-06	0.000134	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.38e-06	0.000133	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.3e-06	0.000131	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.21e-06	0.000128	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.18e-06	0.000128	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.14e-06	0.000127	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.06e-06	0.000125	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—peripheral nervous system neoplasm	5.06e-06	0.000125	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.99e-06	0.000123	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.92e-06	0.000121	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	4.9e-06	0.000121	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.88e-06	0.00012	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.87e-06	0.00012	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.84e-06	0.000119	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	4.82e-06	0.000119	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.79e-06	0.000118	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.75e-06	0.000117	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.56e-06	0.000113	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.49e-06	0.000111	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.46e-06	0.00011	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	4.41e-06	0.000109	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.26e-06	0.000105	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.25e-06	0.000105	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.16e-06	0.000103	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.13e-06	0.000102	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.08e-06	0.000101	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-06	0.000101	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.06e-06	0.0001	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.97e-06	9.81e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.96e-06	9.79e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.91e-06	9.65e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.91e-06	9.64e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.76e-06	9.29e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.51e-06	8.66e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.49e-06	8.61e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.42e-06	8.44e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.4e-06	8.38e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.35e-06	8.26e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.34e-06	8.24e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.19e-06	7.87e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.18e-06	7.86e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.13e-06	7.73e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.95e-06	7.27e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.94e-06	7.25e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.84e-06	7.01e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.62e-06	6.46e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.56e-06	6.32e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.56e-06	6.31e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.5e-06	6.17e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.38e-06	5.89e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	2.35e-06	5.8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.21e-06	5.45e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.85e-06	4.57e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	4.32e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.6e-06	3.96e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	3.53e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.4e-06	3.45e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	3.25e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	3.22e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.12e-06	2.75e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.61e-07	2.13e-05	CbGpPWpGaD
